Press Room
Resources dedicated to journalists and media professionals
The PR department responds to all media requests for information on scientific, medical, technological and entrepreneurial activities at Paris Brain Institute.
It disseminates new results from research teams and connects journalists to a relevant expert to comment on a current issue.
Feel free to contact our press officer to help you develop a topic that relies on state-of-the-art knowledge in neuroscience, neurology or psychiatry.
Press contact
Marie Simon
Email
:
presse@icm-institute.org
Our press documents
Sensory neurons pick up information from our senses and relay it to the rest of the nervous system. But this is not their only mission. In a new study published in the journal Current Biology, Claire Wyart at Paris Brain Institute, and Christina...
02.20.2023
Research, science & health
The European Research Council (ERC) has just published the list of the winners of the grants it is about to distribute. This year, two researchers from at the Paris Brain Institute have been distinguished.
02.07.2023
Research, science & health
The acquisition of reading and writing are complex mechanisms whose subtleties we do not yet understand. Fabien Hauw and Laurent Cohen (Inserm, CNRS, Sorbonne University, AP-HP), neurologists at Paris Brain Institute, hope to uncover how we connect...
02.03.2023
Research, science & health
Disinhibition is one of the main symptoms of the behavioural variant frontotemporal dementia (bvFTD), a type of dementia associated with degeneration of the frontal and temporal lobes of the brain. Patients with bvFTD exhibit behaviours that are...
01.30.2023
Research, science & health
The work of Professor Fanny Mochel (AP-HP, Sorbonne University) at Paris Brain Institute, in collaboration with clinical research teams in eight countries and Spanish biotech Minoryx Therapeutics, has demonstrated the protective effects of...
01.20.2023
Research, science & health
Researchers from Inserm, CNRS, Sorbonne University and clinicians from the AP-HP and at Paris Brain Institute identified one of the mechanisms explaining ketamine effect as an antidepressant. Ketamine, usually used as an anesthetic, was administered...
10.06.2022
Research, science & health
Our useful documents
All
No results found
News that might interest you
Attention-deficit/hyperactivity disorder (ADHD) remains poorly understood from a biological perspective. An international study led by scientists from the Paris Brain Institute and Monash University in Australia suggests that some symptoms may be...
03.17.2026
Research, science & health
Can brain imaging reveal whether a person is affected by depression? This question has driven research for many years. Changes in brain structure have indeed been observed in patients with depression, suggesting that structural MRI might one day help...
03.12.2026
Research, science & health
Artificial intelligence is rapidly transforming the way scientists explore the human brain. To accelerate breakthroughs, the Paris Brain Institute is launching, after its Call for Junior Group Leaders, a Call for Expression of Interest for Senior or...
03.09.2026
Institutional
In order to strengthen the strategic Franco-Indian partnership, which is supported at the very highest level by both the French and Indian authorities, a delegation from Paris Brain Institute went to New Delhi from the 16th to the 20th of February...
03.24.2026
Institutional
Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are eligible for the procedure. For these individuals...
03.06.2026
Research, science & health
Violetta Zujovic is team leader and scientific manager of the facility. Her research focuses on the immune system’s role in myelin repair, which is a key factor in neurological disorders such as multiple sclerosis and certain leukodystrophies. With...
03.04.2026
Portraits